Welcome to our dedicated page for GENPACT news (Ticker: G), a resource for investors and traders seeking the latest updates and insights on GENPACT stock.
Genpact Limited (NYSE: G) is a global professional services firm known for its commitment to delivering transformative business outcomes that shape the future. Established as a spin-off from General Electric in 1998, Genpact leverages its deep industry and functional expertise to provide innovative solutions across a range of sectors including banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing, healthcare, and high-tech.
With over 125,000 employees operating in more than 30 countries, Genpact prides itself on its ability to combine process expertise, technology capabilities, and industry knowledge to help clients achieve significant growth, cost efficiency, and business agility. The company’s proprietary digital business platform, Genpact Cora, integrates advanced technologies such as AI and analytics to streamline operations, enhance decision-making, and drive intelligent operations.
Genpact’s impressive client roster includes more than one-fourth of the Fortune Global 500, reflecting its reputation as a trusted partner for large-scale digital transformation projects. The firm’s dedication to operational excellence has led to collaborations with leading technology platforms like Salesforce, Microsoft, and other industry giants. Recent partnerships include a multi-year engagement with Advantage Solutions to implement industry-leading platforms and a strategic collaboration with Tropicana Brands Group to transform global business services and supply chain operations.
Financially, Genpact has demonstrated consistent growth. For the fiscal year ending December 31, 2023, the company reported annual revenue of $4.5 billion, showing a 2% year-over-year increase despite macroeconomic challenges. The company continues to invest in new technologies and innovative strategies to maintain its competitive edge. In May 2024, Genpact announced a $400 million notes offering intended for general corporate purposes, including the repayment of existing debt, which underscores its strong financial management and strategic foresight.
Genpact’s leadership in the industry is further evidenced by its recognition in various assessments, including Everest Group’s PEAK Matrix® Assessment for financial crime and compliance, where it was named a Leader for the fourth consecutive year. This accolade highlights Genpact’s comprehensive capabilities in areas such as anti-money laundering, fraud management, and risk compliance.
Committed to creating a positive impact, Genpact operates with a purpose-driven approach, aiming to build a world that works better for people. This ethos is reflected in every aspect of the company's operations, from its innovative solutions and strategic partnerships to its sustainable business practices.
Genpact (NYSE: G), a global professional services firm, has been named to the Forbes list of America's Best Employers for Women 2024. This recognition underscores Genpact's commitment to diversity, equity, and inclusion (DEI). The company emphasizes gender balance and supports women through initiatives such as the Women's Leadership Program and scholarships for young girls in India. In 2023, women made up 42% of Genpact's global workforce and 50% of its board, with representation on its leadership council increasing to 47% from 29% in 2022. This award is based on a survey by Forbes and Statista, involving over 150,000 women who rated employers on various DEI metrics. Heather White, Chief Legal Officer, highlighted Genpact's dedication to creating an inclusive work environment.
Genpact (NYSE: G) has been recognized as a Leader in the Everest Group Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® assessment for 2024. This ranking highlights Genpact's outstanding global delivery and AI capabilities, including advanced digital solutions across the regulatory and medical affairs value chain.
Key factors contributing to Genpact's leadership position include:
- Comprehensive suite of digital solutions
- Strategic partnerships with companies like AWS and Veeva
- Cutting-edge AI capabilities, such as Health Agency Q&A and Marketing Authorization Supply Transfer
- Strong presence in the medical technology space
- Expertise in key opinion leader engagement and medical science liaison support
The recognition underscores Genpact's commitment to delivering innovative AI solutions supported by deep industry expertise to clients worldwide in the complex global regulatory environment.
Genpact (NYSE: G) has been supporting embecta (Nasdaq: EMBC), a global diabetes care company, in its spin-off from Becton Dickinson and Company (BD) and its evolution as an independent leader in the diabetes technology market. Genpact's expertise in life sciences, healthcare, data, technology, and AI has enabled them to provide tailored solutions for embecta's needs.
The partnership has focused on modernizing embecta's operations, including implementing a robust ERP system, launching a standardized global operating model, and establishing end-to-end HR, finance, and procurement processes. This support has ensured uninterrupted customer service and supply chain stability, allowing embecta to continue providing insulin injection devices to 30 million people in over 100 countries.
Genpact (NYSE: G) and Reworld™ have announced a strategic partnership to drive sustainability and efficiency. Key points include:
- Reworld™ will utilize Genpact's data, technology, and expertise to optimize finance, procurement, and IT functions
- Genpact joins Reworld™'s ReCredit program, supporting net-zero goals with sustainable carbon offsets
- The partnership aims to modernize legacy systems, reduce operational costs, and improve customer experiences
- Genpact offers sustainability services, including ESG assessment and carbon counting
- Reworld™ provides solutions like ReDirect360™, ReKiln™, ReDrop™, and ReMove for waste management and sustainability
This collaboration demonstrates how sustainability and optimization can work together to achieve shared goals in the waste management industry.
Genpact (NYSE: G), a global professional services firm, has announced a quarterly cash dividend of $0.1525 per share for Q3 2024. This dividend will be paid on September 25, 2024, to shareholders on record as of September 11, 2024. Future dividends are subject to the board of directors' discretion.
Genpact (NYSE: G) will release its second quarter 2024 financial results on August 8, 2024, after U.S. markets close. The company's management will host a conference call to discuss the performance at 5:00 p.m. ET. Interested participants can register to receive a dial-in number and unique PIN for access. A live webcast will be available on Genpact's Investor Relations website, with a replay and transcript accessible post-call.
Genpact (NYSE: G) has entered into a multi-year partnership with ALDI SÜD to transform ALDI's retail operations in the U.S. and Australia. Utilizing Genpact's expertise in data, technology, and AI, the collaboration aims to enhance ALDI's agility and cost efficiency. The partnership will leverage technology platforms such as S/4HANA, Ariba, Blackline, and ServiceNow to streamline operations and maximize ROI. Anil Nanduru, a Global Business Leader at Genpact, emphasized that this digital transformation will help ALDI differentiate itself in the market and drive competitive growth.
Genpact (NYSE: G) has secured the 5th spot in the '50 Best Firms for Data Scientists to Work For 2024' list, as per Analytics India Magazine. This distinction highlights Genpact's dedication to fostering an innovative, learning-centric environment for its data scientists, which includes robust workplace policies and resources for career growth. The company has advanced from the 6th position last year, reflecting its continuous improvement in this domain. The ranking is based on parameters like upskilling, employee engagement, and workplace diversity. Sreekanth Menon, Global Lead for AI at Genpact, emphasized the company's commitment to a people-first culture and leveraging AI to drive significant value. The recognition underscores Genpact's role in shaping the future of data science and AI.
Genpact (NYSE: G) has been recognized as a Leader in Everest Group's 2024 SAP Business Application Services PEAK Matrix® assessment for mid-market enterprises. This recognition highlights Genpact's AI capabilities, extensive talent pool, and comprehensive suite of SAP services. The company has been particularly effective in sectors like consumer packaged goods, life sciences, manufacturing, and retail, across North America and the UK. Everest Group lauds Genpact's market adoption, strategic vision, and client value delivery. The company's strong partnerships and strategic acquisitions further enhance its capabilities in data engineering, analytics, and supply chain management. The mid-market SAP Business Application services sector generates over $10 billion annually, showcasing double-digit growth. Genpact continues to invest in AI-driven solutions and upskilling its workforce to maintain its leadership position.
Genpact (NYSE: G) has been acknowledged as a Leader in Everest Group's 2024 PEAK Matrix® Assessment for insurance intermediaries services. This recognition highlights Genpact's AI-led transformation efforts, which enhance efficiency, scalability, and growth for global clients in sectors such as property, casualty, life, annuities, retirements, and care management services.
Genpact's robust suite of AI, analytics, and automation solutions significantly improves distribution, new business, underwriting, claims, actuarial, and reinsurance processes. This transformation is important for insurers to stay competitive in a fast-evolving market by enhancing efficiency, customer experience, and profitability.
The recognition stems from Genpact's proactive investment in AI and data-focused tools, legacy platform modernization, and generative AI implementations, positioning them as a leader among 15 evaluated providers.